Published :
30 Mar 2013, 02:52 PM
Updated :
09 Aug 2022, 10:26 AM
They were re-elected at an annual general meeting of BAPI.
Rahman is the Vice Chairman of the Beximco Group that owns Beximco Pharmaceuticals Ltd while Muktadir is the Managing Director of Incepta Pharmaceuticals Ltd.
They will serve for the next two years.
The only association of Bangladesh’s burgeoning pharmaceutical industries, BAPI serves as a catalyst for boosting trade and investment in this sector with its 166 member-companies.
The association is also a member of Geneva-based International Federation of Pharmaceutical Manufacturers Association (IFPMA).
With a market size of around $1.2 billion, Bangladesh is almost self-sufficient in medicine production as local companies meet about 97 percent of the national demand.
Besides, at least 3,600 products have been registered in more than 85 countries including the highly-regulated Europe and Latin American markets.
The newly-elected Vice Presidents are Managing Directors of General Pharma Momenul Haque and Medimet Pharma’s Khandaker Tarikul Islam.
Renata Limited’s Managing Director Syed S Kaiser Kabir has been elected as the Treasurer of BAPI.
The elected executive members are Managing Directors of Square Pharma Tapan Chowdhury, Popular Pharma Mostafizur Rahman, Unihealth M Hosaddeq Hossain, People Pharma M M Rahman Khan, Beakon Pharma Md Ebadul Karim, Bio-pharma Md Anwarul Azim, Nuvesta Akter Matin Chowdhury, Amico Pharma Mozibul Islam, JMI Syringe Md Abdur Razzak, GSK Md Azizul Haque, EDCL Kadrul Huda, Techno Drug Shah Jalal Uddin Ahmed, Aristopharma Md Ziaul Haque, Varitas Pharma Habib-e-Millat and Ziska Pharma Aminul Islam Khan and Chief Executive Officer of ACI Mohibuzzaman.